Inhaled triamcinolone with proton pump inhibitor for treatment of vocal process granulomas: A series of 67 granulomas

Annals of Otology, Rhinology and Laryngology

Volumn 119, Issue 5, 2010, Pages 325-330

  Hillel, Alexander T ^a   Lin, Li Mei ^a   Samlan, Robin ^a   Starmer, Heather ^a   Leahy, Kevin ^a   Flint, Paul W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastroesophageal reflux; Hyperfunctional voice abuse; Inhaled steroid; Proton pump inhibitor; Speech therapy; Vocal process granuloma

Indexed keywords

NYSTATIN; PROTON PUMP INHIBITOR; TRIAMCINOLONE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; FEMALE; FOLLOW UP; HUMAN; INTUBATION; LARYNX GRANULOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SEX DIFFERENCE; THRUSH; TREATMENT RESPONSE;

EID: 77952294133     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941011900509     Document Type: Article

References (26)

1. Hoffman HT, Overholt E, Karnell M, McCulloch TM. Vocal process granuloma. Head Neck 2001;23:1061-1074.
2. Jackson C. Contact ulcer of larynx. Ann Otol Rhinol Laryngol 1928;37:227-238.
3. Jackson C, Jackson CL. Contact ulcer of the larynx. Arch Otolaryngol 1935;22:1-15.
4. Clausen RJ. Unusual sequelae of tracheal intubation. Proc R Soc Med 1932;25:1507.
5. New GB, Devine KD. Contact ulcer granuloma. Ann Otol Rhinol Laryngol 1949;58:548-558.
6. Cherry J, Margulies SI. Contact ulcer of the larynx. Laryngoscope 1968;78:1937-1940.
7. Delahunty JE, Cherry J. Experimentally produced vocal cord granulomas. Laryngoscope 1968;78:1941-1947.
8. Havas TE, Priestley J, Lowinger DS. A management strategy for vocal process granulomas. Laryngoscope 1999;109:301-306. (Pubitemid 29075576)
9. Ylitalo R, Ramel S. Extraesophageal reflux in patients with contact granuloma: a prospective controlled study. Ann Otol Rhinol Laryngol 2002;111:441-446.
10. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(suppl 53):1-78.
11. Peacher G, Holinger P. Contact ulcer of larynx: role of vocal reeducation. Arch Otolaryngol 1947;46:617-623.
12. Bloch CS, Gould WJ, Hirano M. Effect of voice therapy on contact granuloma of the vocal fold. Ann Otol Rhinol Laryngol 1981;90:48-52. (Pubitemid 11191786)
13. Ward PH, Zwitman D, Hansen D, Berci G. Contact ulcers and granulomas of the larynx: new insights into their etiology as a basis for more rational treatment. Otolaryngol Head Neck Surg 1980;88:262-269. (Pubitemid 10066618)
14. Emami AJ, Morrison M, Rammage L, Bosch D. Treatment of laryngeal contact ulcers and granulomas: a 12-year retrospective analysis. J Voice 1999;13:612-617. (Pubitemid 30007819)
15. Roh HJ, Goh EK, Chon KM, Wang SG. Topical inhalant steroid (budesonide, Pulmicort nasal) therapy in intubation granuloma. J Laryngol Otol 1999;113:427-432.
16. Ylitalo R, Lindestad PA. A retrospective study of contact granuloma. Laryngoscope 1999;109:433-436.
17. Nasri S, Sercarz JA, McAlpin T, Berke GS. Treatment of vocal fold granuloma using botulinum toxin type A. Laryngoscope 1995;105:585-588.
18. McFerran DJ, Abdullah V, Gallimore AP, Pringle MB, Croft CB. Vocal process granulomata. J Laryngol Otol 1994;108:216-220.
19. Snow JC, Hirano M, Balough K. Postintubation granuloma of the larynx. Anesth Analg 1966;45:425-428.
20. Wani MK, Woodson GE. Laryngeal contact granuloma. Laryngoscope 1999;109:1589-1593.
21. Holinger PH, Johnston KC. Contact ulcer of the larynx. J Am Med Assoc 1960;172:511-515.
22. Peacher GM. Vocal therapy for contact ulcer of the larynx. A follow-up of 70 patients. Laryngoscope 1961;71:37-47.
23. Wenig BM, Heffner DK. Contact ulcers of the larynx. A reacquaintance with the pathology of an often underdiagnosed entity. Arch Pathol Lab Med 1990;114:825-828.
24. Allen DB. Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Adv Pediatr 2006;53:101-110.
25. Nelson HS, Kane RE, Petillo J, Banerji D. Long-term safety of a nonchlorofluorocarbon-containing triamcinolone acetonide inhalation aerosol in patients with asthma. Azmacort HFA Study Group. J Asthma 2000;37:145-152. (Pubitemid 30241697)
26. Barnes NC, Hallett C, Harris TA. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med 1998;92:95-104. (Pubitemid 28112049)